May 02, 2012 17:40 EDT BioNavis Ltd BioNavis Ltd. announces the winners of the International Multi-Parametric Surface Plasmon Resonance (MP-SPR) Contest. The winning proposals from New Zealand and from Poland are both based on assessing new types of active polymers. The applications of such smart polymers include solar, biosensors, smart implants, drug delivery, and toxicology for instance.
Jan 31, 2012 06:06 EST BioNavis Ltd Traditional surface plasmon resonance (SPR) has been used in drug discovery for more than 20 years. Now, with BioNavis SPR Navi 200 and SPR Navi 220A instruments, SPR phenomena can be used also in biophysics, biomaterials, and biosensor development. Furthermore, SAMP-SPR by BioNavis and Episentec enhances the capabilities of the SPR technology increasing its sensitivity and specificity 100-fold!
Dec 07, 2011 04:52 EST Tobii Technology Tobii Studio 3.0 features a new AOI tool that supports both static and dynamic areas of interest in a broad range of stimuli.
Dec 01, 2011 11:15 EST Halo Genomics Uppsala, Sweden, December 1, 2011 – Halo Genomics today announced it has been acquired by Agilent Technologies Inc. (NYSE: A), the world’s premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications.
Nov 22, 2011 03:00 EST Halo Genomics Halo Genomics AB, a company providing products for next generation targeted sequencing, today announced the appointment of D-MARK Biosciences as its distributor in Canada.
Nov 21, 2011 09:00 EST Olink Bioscience Olink Bioscience, a Sweden based biotechnology company focused on innovative protein detection technologies, has entered into a distribution agreement with Bethyl Laboratories, Inc. Together with Bethyl Olink Bioscience will continue to expand the distribution of the Duolink® product line in the US market.
Nov 10, 2011 04:00 EST Halo Genomics UPPSALA, Sweden, November 10, 2011 – Halo Genomics AB, a company providing products for next generation targeted resequencing, will develop HaloPlex PCR technology for large scale methylation analysis
Nov 07, 2011 07:00 EST Viropharma The Swedish specialty pharma company, DuoCort Pharma, announced today that the European Commission has granted a European Marketing Authorisation for Plenadren® (hydrocortisone, modified release tablet), an orphan drug for treatment of adrenal insufficiency in adults, bringing these patients their first pharmaceutical innovation in over 50 years.
Oct 27, 2011 07:33 EDT Viropharma DuoCort AB announces it has signed a definitive agreement to sell DuoCort Pharma AB and its orphan drug Plenadren® to the biopharmaceutical company ViroPharma Incorporated. Plenadren® is a new treatment for adrenal insufficiency, also called Addison´s disease. The total potential deal value exceeds one billion SEK of which 220 million SEK will be paid by ViroPharma on closing.
Oct 25, 2011 03:00 EDT Halo Genomics Halo Genomics AB, a company providing products for next generation targeted resequencing, has strengthened its sales organization and established a sales office in Cambridge, MA